Feature Rotating Article - BioPharm International

ADVERTISEMENT

Feature Rotating Article

Key Considerations in Biosimilars Development

October 1, 2012

Understanding opportunities and challenges across all major phases of development.

Considerations in Outsourced Vaccine Manufacturing

October 1, 2012

Marco Chacon of Paragon Bioservices discusses the challenges associated with outsourced vaccine manufacturing.

A Manufacturing-Capacity Sharing Model

October 1, 2012

The manufacturing capacity-sharing model between Merck and MedImmune ushers in a new paradigm of "co-opetition."

Considerations in Vaccine Packaging and Delivery Systems

October 1, 2012

Glenn Thorpe of West Pharmaceutical Services gives an update on packaging and delivery methods for vaccines.

Correlating Product Lifecycle and Manufacturing Site Characteristics with Product Deviations

October 1, 2012

MIT survey results address product and site characteristics that statistically correlate with quality performance.

Training the Biopharma Industry

September 1, 2012

Using a competency-based approach to effectively train biopharmaceutical industry staff.

In-Depth Validation of Closed-Vial Technology

September 1, 2012

The authors describe a validation master plan for closed-vial filling technology.

Regulatory Challenges in the QbD Paradigm

September 1, 2012

The authors demonstrate how an integrated model is helping to achieve regulatory flexibility. This article is part of a special section on biopharmaceutical trends.

Challenges and Opportunities for Biosimilars Developers

September 1, 2012

Howard Levine of BioProcess Technology Consultants talks about what industry needs to know to enter the biosimilars game in the US.

ADVERTISEMENT

ADVERTISEMENT

Click here